Company Filing History:
Years Active: 2011
Title: David John Bushnell: Innovator in Hepatitis C Treatment
Introduction
David John Bushnell is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis C. His innovative work has led to the development of a unique compound that holds promise for patients suffering from this viral infection.
Latest Patents
Bushnell holds a patent for "Biphenyl derivatives and their use in treating hepatitis C." This patent describes the use of a compound that is a biphenyl derivative of a specific formula, or a pharmaceutically acceptable salt thereof, for the treatment of hepatitis C. The variables and details of this compound are thoroughly outlined in the patent documentation.
Career Highlights
Throughout his career, Bushnell has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AstraZeneca and Arrow Therapeutics Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Bushnell has collaborated with several professionals in his field, including Christopher James Wheelhouse and Alexander James Floyd Thomas. These collaborations have likely enriched his research and development efforts, leading to advancements in hepatitis C treatment.
Conclusion
David John Bushnell's contributions to the treatment of hepatitis C through his innovative patent demonstrate his commitment to improving healthcare. His work continues to inspire advancements in pharmaceutical research and development.